Retina/Vitreous

Top Story

FDA approves Eylea 12-week dosing for wet AMD

August 17, 2018
Point/Counter

When treating patients with age-related macular degeneration, do you perform bilateral same-day intravitreal injections?

Ocular Surgery News U.S. Edition, August 25, 2018
Point “Git-R-Done!” That is what my patients say to me whenever I ask them if they prefer bilateral intravitreal injections on the same day. This is the…
Cover Story

Treat-and-extend increasingly gains favor for individualized, proactive management of neovascular AMD

Ocular Surgery News U.S. Edition, August 25, 2018
An appropriate treatment modality is key to the success of anti-VEGF therapy in neovascular age-related macular degeneration. Over time, based on the results of clinical…
Grand Rounds at the New England Eye Center

Elderly man presents with severe, intermittent left eye pain

Ocular Surgery News U.S. Edition, August 25, 2018
Huan Mills, MD; Jay S. Duker, MD
An 80-year-old retired firefighter with a history of wet age-related macular degeneration since 1990 presented to the retinal specialist for new intermittent severe left…
More Headlines »
Clinical Science

Outcomes and Complications of Hydrogel Scleral Explant Removal

Ophthalmic Surgery, Lasers and Imaging Retina, September 2012, Volume 43 Issue 5
To report symptoms of extrusion of hydrogel explants after retinal detachment (RD) repair and the outcomes and…
More »
CME

Uveitis 101 for Busy Retina Specialists

Case Discussions: Medical and Surgical Approaches in Managing Patients With Uveitis

This activity presents an update on differential diagnosis of noninfectious uveitis of the posterior segment (NIU-PS)…
More »
Resource Centers
Video
Meeting News

VIDEO: OCT angiography quantifies retinal damage due to radiation retinopathy

August 8, 2018
More »

FDA approves Eylea 12-week dosing for wet AMD

August 17, 2018
The FDA has approved a supplemental biologics license application for a 12-week dosing schedule of Eylea injection in wet age-related macular…

Point/Counter

When treating patients with age-related macular degeneration, do you perform bilateral same-day intravitreal injections?

Ocular Surgery News U.S. Edition, August 25, 2018
Point “Git-R-Done!” That is what my patients say to me whenever I ask them if they prefer bilateral intravitreal injections on the same…

Cover Story

Treat-and-extend increasingly gains favor for individualized, proactive management of neovascular AMD

Ocular Surgery News U.S. Edition, August 25, 2018
An appropriate treatment modality is key to the success of anti-VEGF therapy in neovascular age-related macular degeneration. Over time, based on the…

Grand Rounds at the New England Eye Center

Elderly man presents with severe, intermittent left eye pain

Ocular Surgery News U.S. Edition, August 25, 2018
Huan Mills, MD; Jay S. Duker, MD
An 80-year-old retired firefighter with a history of wet age-related macular degeneration since 1990 presented to the retinal specialist for new…

Lindstrom's Perspective

Better monitoring, delivery systems needed for anti-VEGFs

Ocular Surgery News U.S. Edition, August 25, 2018
Richard L. Lindstrom, MD
I do not personally perform intravitreal anti-VEGF injections, but I have many patients, friends and family members of friends who are being or have…

Web Vision Technologies awarded grants to develop devices for NASA

August 15, 2018
Web Vision Technologies has received two grants to develop vision testing devices for use on the International Space Station, the company announced…

FDA issues complete response letter on Eylea 12-week dosing

August 14, 2018
The FDA has issued a complete response letter regarding Regeneron’s supplemental biologics license application for 12-week dosing of Eylea, the…

In the Journals

Valproic acid no better than placebo for autosomal dominant retinitis pigmentosa

August 14, 2018
The results of a clinical trial did not provide support for the use of orally administered valproic acid for the treatment of autosomal dominant…

Meeting News

Vigilance needed in screening juvenile patients for uveitis

August 12, 2018
FORT WORTH, Texas — Uveitis among young patients with oligoarticular juvenile idiopathic arthritis is often asymptomatic, but comes with a very…

Top ophthalmology news of the week

August 12, 2018
Here are some of the latest top stories on Healio.com/OSN:

Meeting NewsVideo

VIDEO: More individualized treatment needed for DR, DME patients

August 10, 2018
VANCOUVER, British Columbia — At the American Society of Retina Specialists meeting, Geeta A. Lalwani, MD, discusses applying results from the…

Meeting NewsVideo

VIDEO: BOULEVARD trial advances molecule for treatment of DME

August 9, 2018
VANCOUVER, British Columbia — At the American Society of Retina Specialists annual meeting, Rishi P. Singh, MD, discusses findings from the…

Meeting NewsVideo

VIDEO: OCT angiography quantifies retinal damage due to radiation retinopathy

August 8, 2018
VANCOUVER, British Columbia — At the American Society of Retina Specialists annual meeting, Amir Kashani, MD, of the USC Roski Eye…

Allergan, Editas to develop CRISPR genome editing medicine

August 8, 2018
Allergan has joined with the genome editing company Editas Medicine to develop and commercialize EDIT-101 CRISPR genome editing medicine for the…

Aerie, DSM expand collaborative agreement

August 8, 2018
Aerie Pharmaceuticals and DSM Biomedical have expanded a collaborative research, development and license agreement, according to a press release. The…

Continuous glucose monitor may help reduce incidence of diabetic eye disease

August 7, 2018
Diabetes is a growing health problem. As an ophthalmologist, I see it in my office. So does the CDC. According to the CDC, “diabetes was the…

Meeting NewsVideo

VIDEO: Visual acuity gains demonstrated in PEACHTREE trial

August 7, 2018
VANCOUVER, British Columbia Steven Yeh, MD, describes efficacy and safety findings from the PEACHTREE trial, which he presented at the

Meeting News

Early study results positive for AU-011 in patients with choroidal melanoma

August 7, 2018
VANCOUVER, British Columbia — A phase 1b/2 clinical trial of AU-011, a light-activated, vision-sparing, tumor cell selective therapy for…

Grand Rounds at the New England Eye Center

Young woman presents with painful ophthalmoplegia in left eye

Ocular Surgery News U.S. Edition, August 10, 2018
Huan Meng Mills, MD; Alison Callahan, MD
A 20-year-old woman presented to Tufts New England Eye Center with 1 day of progressively worsening left eyelid swelling and pain with eye movement…

RXI-109 for retinal scarring safe, well tolerated in phase 1/2 study

August 6, 2018
RXI-109 injection for retinal scarring in neovascular age-related macular degeneration was safe and well tolerated in a phase 1/2 clinical trial…

More Headlines »